Table 2.
Total isolates | CAZ-AVI resistant isolates | CAZ-AVI susceptible isolates | Sensitivity % [95% CI] |
Specificity % [95% CI] |
PPV % [95% CI] |
NPV % [95% CI] |
|
---|---|---|---|---|---|---|---|
KPC-producing Enterobacteralesa | 153 | 91 | 62 | 100 [96–100%] | 71 [58–81.8] | 83.5 [77.4–88.2] | 100 |
MβL-producing Enterobacteralesb | 36 | 36 | 0 | 100 [90.3–100] | - | 100 | - |
OXA-48-like-producing Enterobacteralesc | 8 | 0 | 8 | - | 87.5 [47.3–99.7] | 100 | |
Carbapenem-resistant non-carbapenemase producing-Enterobacteralesd | 5 | 0 | 5 | - | 80 [28.4–99.5] | 100 | |
Carbapenem-resistant Pseudomonas aeruginosa | 64 | 21 | 43 | 100 [83.9–100] | 90.7 [77.9–97.4] | 84 [67.4–93] | 100 |
Carbapenem-resistant A. baumannii complex | 20 | 20 | 0 | 100 [83.2–100] | - | 100 | - |
All isolates grown on CRE mediume | 365 | 168 | 197 | 100 [97.8–100] | 86.8 [81.3–91.2] | 86.6 [81.9–90.2] | 100 |
aK. pneumoniae, n = 145; E. coli, n = 8
bEnterobacter cloacae, n = 18, E. coli n = 9; K. pneumoniae, n = 7; Morganella morganii, n = 2
cE. coli, n = 5; K. pneumoniae, n = 3
dK. pneumoniae, n = 3; E. coli, n = 2
eIncluding carbapenem-susceptible and/or non-carbapenemase-producing isolates